Rocket Pharmaceuticals, Inc. (RCKT)

Rocket Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	75.95	163.64	55.9	140.52	232.69	297.1
Short-Term Investments	146.81	208.7	317.27	215.88	156.05	185.62
Cash & Short-Term Investments	222.76	372.34	373.18	356.39	388.74	482.72
Cash Growth	-5.48%	-0.22%	4.71%	-8.32%	-19.47%	58.73%
Prepaid Expenses	4.92	5.85	5.05	7.67	3.32	4.63
Total Current Assets	227.68	378.18	378.22	364.06	392.06	487.35
Property, Plant & Equipment	74.17	83.32	87.59	77.65	72.35	70.64
Long-Term Investments	-	-	34.32	43.28	-	-
Goodwill	39.15	39.15	39.15	39.15	30.82	30.82
Other Intangible Assets	25.15	25.15	25.15	25.72	-	-
Other Long-Term Assets	1.88	1.89	1.91	1.95	1.8	2.02
Total Assets	368.03	527.7	566.34	551.81	497.02	590.82
Accounts Payable	2.67	1.63	1.77	2.27	0.48	0.84
Accrued Expenses	22.83	36.02	29.8	30.54	17.81	22.29
Current Portion of Long-Term Debt	-	-	-	-	-	4.88
Current Portion of Leases	2.91	2.86	2.72	2.51	2.55	2.27
Current Unearned Revenue	-	-	-	0.6	0.6	0.59
Other Current Liabilities	2.76	0.19	14.21	3.25	0.73	1.76
Total Current Liabilities	31.17	40.68	48.51	39.17	22.17	32.62
Long-Term Debt	-	-	-	-	-	35.07
Long-Term Leases	22.13	22.64	22.33	20.36	20.05	19.49
Other Long-Term Liabilities	1.06	1.14	2.94	2.6	0.08	0.14
Total Liabilities	54.36	64.47	73.77	62.12	42.3	87.31
Common Stock	1.08	1.07	0.9	0.79	0.65	0.61
Additional Paid-In Capital	1,711	1,680	1,451	1,203	946.15	825.79
Retained Earnings	-1,399	-1,218	-959.37	-713.78	-491.91	-322.84
Treasury Stock	-	-	-	-0.05	-	-
Comprehensive Income & Other	-0.01	0.07	0.32	-0.36	-0.16	-0.04
Total Common Equity	313.67	463.23	492.57	489.69	454.72	503.52
Shareholders' Equity	313.67	463.23	492.57	489.69	454.72	503.52
Total Liabilities & Equity	368.03	527.7	566.34	551.81	497.02	590.82
Total Debt	25.05	25.5	25.04	22.87	22.6	61.7
Net Cash (Debt)	197.71	346.84	348.13	333.53	366.14	421.02
Net Cash Growth	-5.86%	-0.37%	4.38%	-8.91%	-13.04%	64.03%
Net Cash Per Share	1.84	3.66	4.14	4.89	5.79	7.60
Filing Date Shares Outstanding	108.22	106.63	90.5	79.35	64.51	61.78
Total Common Shares Outstanding	108.21	106.45	90.28	79.12	64.51	61
Working Capital	196.51	337.5	329.72	324.89	369.89	454.73
Book Value Per Share	2.90	4.35	5.46	6.19	7.05	8.25
Tangible Book Value	249.37	398.93	428.27	424.81	423.91	472.7
Tangible Book Value Per Share	2.30	3.75	4.74	5.37	6.57	7.75
Machinery	47.98	48.85	44.58	35.61	25.21	19.84
Leasehold Improvements	7.33	7.28	6.72	0.59	0.41	0.03

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q